Evidence map›Paper›PMID 40590205›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2025

Bi-allelic loss-of-function variants in POC5 cause a syndromic retinal, endocrine, and neuromuscular ciliopathy.

Anneke T Vulto-van Silfhout, Ingrid M Jazet, Suzanne Yzer, Jeroen Pas, Serwet Demirdas, Elisabeth F C van Rossum, Alberta A H J Thiadens, Ronald van Beek, Lonneke Haer-Wigman, Daniela Q C M Barge-Schaapveld and 34 more

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Centriolar Protein POC5 Regulates Human Adipogenesis and Cellular Senescence: Insights From a Novel Metabolic Ciliopathy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors.

Anneke T Vulto-van SilfhoutDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address: anneke.vulto-vansilfhout@radboudumc.nl.
Ingrid M JazetDivision of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Suzanne YzerDepartment of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
Jeroen PasDepartment of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
Serwet DemirdasDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Elisabeth F C van RossumDivision of Endocrinology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Alberta A H J ThiadensDepartment of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Ronald van BeekDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Lonneke Haer-WigmanDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Daniela Q C M Barge-SchaapveldDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Charlotte Brasch-AndersenDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Simon FrostDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Miriam BauwensCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Elfride De BaereCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Irina BalikovaDepartment of Ophthalmology, University Hospital Leuven, Leuven, Belgium.
Filip Van den BroeckDepartment of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
Monika Weisz-HubshmanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.
Pascal JosetMedical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Peter MinyMedical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Isabel FilgesMedical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Susanne KohlMolecular Genetics Laboratory, Institute for Ophthalmic Research, Center for Ophthalmology, University, Tübingen, Germany.
Pietro De AngeliMolecular Genetics Laboratory, Institute for Ophthalmic Research, Center for Ophthalmology, University, Tübingen, Germany.
Laura KühleweinUniversity Eye Hospital, Center for Ophthalmology, Eberhard Karls University, Tübingen, Germany.
Jan-Philipp BodenbenderUniversity Eye Hospital, Center for Ophthalmology, Eberhard Karls University, Tübingen, Germany.
Tobias HaackInstitute for Medical Genetics and Applied Genomics, Eberhard Karls University, Tübingen, Germany.
Karin PothsInstitute for Medical Genetics and Applied Genomics, Eberhard Karls University, Tübingen, Germany.
Lidia Fernandez-CaballeroDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Marta CortonCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Fiona Blanco KellyDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Carmen AyusoDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Peggy Martínez-EstebanNeurofisiologia Clínica, Instituto Nacional de Salud del Niño San Borja, Lima, Perú.
John VissingCopenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Jordi Díaz-ManeraThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Volker StraubThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Ana TöpfThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Siying LinNIHR Biomedical Research Centre, Moorfields Eye Hospital and the UCL Institute of Ophthalmology, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Gavin ArnoNIHR Biomedical Research Centre, Moorfields Eye Hospital and the UCL Institute of Ophthalmology, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom; Division of Research, Greenwood Genetic Center, Greenwood, South CA.
William L MackenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Jennifer SpillaneDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom.
Radha RamachandranDepartment of Adult Inherited Metabolic Diseases, Metabolic Medicine and Chemical Pathology, Guys and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom.
Erik de VriezeDepartment of Otorhinolaryngology, Radboud University Medical Center, Nijmegen, The Netherlands.
Tjakko van HamDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Susanne RoosingDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Machteld M OudDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

Statistical Methods for Gene Regulatory Analysis From Single Cell Genomics DataP20GM139769 · NIGMS · CLEMSON UNIVERSITY · PI ANHOLT, ROBERT R. H, ARNO, GAVIN · 2021 to 2025
$10.8M
NIGMS NIH HHS P20 GM139769
6 · The paper itself

Abstract

purposeA homozygous loss-of-function (LoF) variant in POC5 was previously described in an individual with retinitis pigmentosa. We identified POC5 variants in 12 probands with a syndromic phenotype. We aim to define the phenotype spectrum and molecular mechanism associated with biallelic POC5 LoF variants.

methodsWe studied a cohort of 12 families with bi-allelic LoF POC5 variants and performed detailed phenotype analysis. POC5 localization studies were performed in 3 proband-derived fibroblast cell lines.

resultsDetailed phenotyping of probands with POC5 variants expands the phenotype spectrum beyond ocular manifestations. This syndrome causes not only rod-cone dystrophy but also diabetes mellitus with severe insulin resistance and partial lipodystrophy, kidney disease, and muscle cramps. The POC5 protein plays an essential role during cell cycle and cilium formation. Interestingly, POC5 localization studies in 3 proband-derived fibroblast cell lines show aberrant localization suggesting a ciliary defect. The phenotypes of the 12 families in this study fit well within the ciliopathy phenotype spectrum, except for lipodystrophy, which is not common in ciliopathies.

conclusionWe describe a multiorgan syndrome caused by bi-allelic LoF variants in POC5. This underscores the pleiotropic effects of POC5 variants and highlights the significance of adipose tissue and metabolic dysfunction in ciliopathies.

Indexed as

Cell Cycle ProteinsCiliopathiesEndocrine System DiseasesAdolescentAdultAllelesChildCiliaFemaleFibroblastsHumansLoss of Function MutationMalePedigreePhenotypeRetinitis PigmentosaCell Cycle ProteinsCiliopathyInsulin resistanceMuscle crampsRenal diseaseSyndrome

Identifiers

PMID40590205
PMCPMC12622366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.